New Search

If you are not happy with the results below please do another search

4897 search results for:

3821

Tracking down genetic influences on brain disorders

New findings will help to identify the genetic causes of brain disorders: researchers at the Universities of Basel, Bonn and Cologne have presented a systematic catalogue of specific variable locations in the genome that influence gene activity in the human hippocampus.Individual differences in gene regulation contribute to the development of numerous multifactorial disorders. Researchers are […]

3822

Researcher develops a molecular taxonomy for hair disorders

Two decades ago, oncologists realized that molecular biologists could see medically important differences between tumours that looked identical to pathologists. Molecular biologists could read information in the genome that helped to increase the precision of diagnoses, guide treatment strategies, and improve health outcomes.Now, a research team from Columbia University has taken the first steps toward […]

3823

Orion to sell its Orion Diagnostica division

Orion Corporation (“Orion”) had announced last January that it was evaluating strategic alternatives of the Group’s Orion Diagnostica business division and had decided to investigate the possible sale of Orion Diagnostica as one alternative. Orion has now signed an agreement on the sale of all shares in Orion Diagnostica Oy (i.e. the Orion Diagnostica business […]

3824

Beckman Coulter sponsors top-ranked sepsis clinical guide app

Beckman Coulter has announced its exclusive sponsorship of the ESCAVO Sepsis Clinical Guide (Sepsis app), a point-of-care medical reference mobile application for healthcare professionals who manage septic patients in acute-care settings. Beckman Coulter’s sponsorship of the Sepsis app ensures this important tool will remain free for all users and that content will continue to be […]

3825

ELITechGroup and R-Biopharm announce a worldwide agreement

ELITechGroup, a leading company in sample-to-result molecular diagnostics, and R-Biopharm, a globally active life science company, have announced a worldwide agreement to strengthen their positions in molecular infectious disease testing. Under this agreement, R-Biopharm and ELITechGroup will cooperate in the development, production and marketing of Real-Time PCR reagents. “We are very pleased to have won […]

3826

Genetic variants linked to type 2 diabetes identified in Chinese populations

Researchers investigated genomes from diverse Chinese populations to identify new and known genetic variants that contribute to a person’s blood sugar level and risk of Type 2 diabetes. Karen Mohlke at the University of North Carolina at Chapel Hill, Wei Huang at the Chinese National Human Genome Center and Shanghai Industrial Technology Institute, and their […]

3827

New point-of-care test quickly detects Lyme neuroborreliosis

A new research-based point-of-care test has been developed in Finland for detecting the Lyme neuroborreliosis spread by ticks. The test makes rapid initiation of antibiotic treatment possible for patients with borreliosis, which reduces the post-treatment symptoms related to the disease. At the same time, unnecessary antibiotic treatments can be avoided. The diagnosis of Lyme neuroborreliosis, […]

3828

Genetic link to IBS identified in women

New research coordinated from Karolinska Institutet links certain DNA variants to increased risk of irritable bowel syndrome (IBS) in women. The findings might help explain why IBS is more common in women than in men. Irritable bowel syndrome is the most common gastrointestinal disorder. More than 10 per cent of the population, women more than […]

3829

Scientists help redefine how cancer is categorized

Van Andel Research Institute (VARI) announced that the work of its scientists is featured in 27 papers focused on the output of The Cancer Genome Atlas (TCGA). The findings are the result of a global scientific collaboration and mark the culmination of TCGA, a multi-institutional, joint effort between the National Cancer Institute (NCI) and the […]

3830

Machine learning finds tumour gene variants and sensitivity to drugs

Matching unique genetic information from cancer patients’ tumours with treatment options – an emerging area of precision medicine efforts – often fails to identify all patients who may respond to certain therapies. Other molecular information from patients may reveal these so-called “hidden responders,” according to a Penn Medicine. “Targeted sequencing can find individuals with certain […]